Physician profile
David Collard
NPI 1659783967
$1,304.93
in general payments reported to CMS, 2019-2025
10 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.86 · 2020: $750 · 2021: $12.65 · 2022: $54.67 · 2023: $156 · 2024: $115 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biopro, INC. | $750.00 | 2020 | |
| Organogenesis INC. | $163.32 | 2019-2025 | Via Matrix |
| Convatec INC. | $140.38 | 2023 | |
| Fusion Orthopedics USA, LLC | $108.35 | 2025 | |
| Triad Life Sciences INC. | $54.67 | 2022 | |
| Boston Scientific Corporation | $28.60 | 2019 | |
| Medartis INC. | $16.79 | 2019 | |
| Nevro Corp. | $15.12 | 2023 | Senza |
| Aroa Biosurgery Incorporated | $15.05 | 2019 | |
| Abbott Laboratories | $12.65 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Collard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.